These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 23277614

  • 1. Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
    Lambert-Messerlian GM, Palomaki GE, Eklund EE, Kloza EM, Neveux LM, Phipps MG, Canick JA.
    J Med Screen; 2012 Dec; 19(4):164-70. PubMed ID: 23277614
    [Abstract] [Full Text] [Related]

  • 2. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM.
    N Engl J Med; 1996 May 09; 334(19):1231-6. PubMed ID: 8606718
    [Abstract] [Full Text] [Related]

  • 3. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D, Bradbury I, Malone F, D'Alton M, Summers A, Huang T, Ball S, Baker A, Nix B, Aitken D, Crossley J, Cuckle H, Spencer K.
    Health Technol Assess; 2010 Jul 09; 14(33):1-80. PubMed ID: 20624355
    [Abstract] [Full Text] [Related]

  • 4. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan 09; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 5. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

  • 6. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM.
    J Med Screen; 1998 Nov 10; 5(3):115-9. PubMed ID: 9795869
    [Abstract] [Full Text] [Related]

  • 7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Nov 10; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 8. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL.
    J Med Screen; 1996 Nov 10; 3(2):58-62. PubMed ID: 8849760
    [Abstract] [Full Text] [Related]

  • 9. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ, Spencer K.
    Prenat Diagn; 2005 Aug 10; 25(8):693-9. PubMed ID: 16050001
    [Abstract] [Full Text] [Related]

  • 10. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ, Bestwick JP, Morris JK.
    Prenat Diagn; 2006 Jun 10; 26(6):514-23. PubMed ID: 16739232
    [Abstract] [Full Text] [Related]

  • 11. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M, Nørgaard-Pedersen B.
    Clin Genet; 2005 Jul 10; 68(1):35-9. PubMed ID: 15952984
    [Abstract] [Full Text] [Related]

  • 12. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG.
    Prenat Diagn; 1996 Feb 10; 16(2):143-53. PubMed ID: 8650125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Measuring maternal serum screening markers for Down's syndrome in plasma collected for cell-free DNA testing.
    Lambert-Messerlian GM, Eklund EE, Neveux LM, Palomaki GE.
    J Med Screen; 2017 Sep 10; 24(3):113-119. PubMed ID: 28756761
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun 10; 28(3):332-5. PubMed ID: 21644235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 10; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.